Relationship between tumour angiogenesis and expression of cyclo-oxygenase-2 and vascular endothelial growth factor-A in human renal cell carcinoma

J Int Med Res. 2015 Feb;43(1):110-7. doi: 10.1177/0300060514545799. Epub 2014 Dec 8.

Abstract

Objective: *These authors contributed equally to this work. To study the relationship between tumour angiogenesis and expression of cyclo-oxygenase (COX)-2 and vascular endothelial growth factor (VEGF)-A in human renal cell carcinoma.

Methods: Archival samples of primary human renal cell carcinoma tissue and surrounding normal renal tissue (control samples) obtained from patients diagnosed with renal cell carcinoma were analysed for COX-2 and VEGF-A expression by immunohistochemistry using specific monoclonal antibodies. Tumour microvasculature was examined using factor VIII-related antigen antibody staining.

Results: A total of 33 renal cell carcinoma and 12 control renal tissue specimens were included. COX-2 and VEGF-A genes were overexpressed in tumour specimens compared with normal epithelia. A significant correlation was found between COX-2 and VEGF-A expression. Microvessel density was found to be increased in tumour tissues that expressed COX-2 and VEGF-A.

Conclusion: Microvessel density was increased in tumour tissues that expressed COX-2 and VEGF-A, suggesting that COX-2 and VEGF-A are related to tumour angiogenesis in human renal cell carcinoma.

Keywords: Renal cell carcinoma; cyclooxygenase-2; immunohistochemistry; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclo-oxygenase); vascular endothelial growth factor-A.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Renal Cell / blood supply*
  • Carcinoma, Renal Cell / enzymology*
  • Carcinoma, Renal Cell / pathology
  • Cell Line, Tumor
  • Cyclooxygenase 2 / metabolism*
  • Female
  • Humans
  • Immunohistochemistry
  • Kidney Neoplasms / blood supply*
  • Kidney Neoplasms / enzymology*
  • Kidney Neoplasms / pathology
  • Male
  • Microvessels / pathology
  • Middle Aged
  • Neovascularization, Pathologic / enzymology*
  • Neovascularization, Pathologic / pathology
  • Vascular Endothelial Growth Factor A / metabolism*

Substances

  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Cyclooxygenase 2
  • PTGS2 protein, human